TOPEKA (KSNT) - The Food and Drug Administration (FDA) says multiple eye ointment products are being recalled due to a lack of sterilization.
The FDA said Brassica Pharma Pvt. Ltd. based out of India is voluntarily recalling several of its eye ointments as a recent inspection found the products lacked sterility. This poses a health risk to those using the eye ointment products in the form of eye infections. Products applied directly to the eyes can bypass a person's natural defenses, leading to a greater risk of infection.
No reports of illness have been received to date by the FDA in connection to the recalled eye ointments. All of the recalled products have expiration dates ranging from February 2024 to September 2025. Each product was sold in a cardboard box in a size 3.5 gram tube.
The recalled products were sold nationwide to retailers like Walmart, CVS and AACE Pharmaceuticals Inc. More information on the recalled eye ointments can be found below:
If you purchased any of the above products, the FDA encourages you to stop using them and return them to the place of purchase. If you have any health concerns, you are encouraged to contact your healthcare provider.
If you have questions for Brassica Pharma Pvt. Ltd., you can contact the company at 1-833-225-9564 or send an email to info@brassicapharma.com. If you have experienced illness in connection to the recalled eye ointment products, you can make a report to the FDA's MedWatch Adverse Event Reporting program online, by mail or fax. To report by mail or fax, click here to download a form or call 1-800-332-1088. You can submit forms by fax through 1-800-FDA-0178.
For more Kansas news, click here. Keep up with the latest breaking news in northeast Kansas by downloading our mobile app and by signing up for our news email alerts. Sign up for our Storm Track Weather app by clicking here.
Follow Matthew Self on X (Twitter): https://twitter.com/MatthewLeoSelf
